drugset

drugset / Trial / NCT00719511

Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutaneous Allergen Administration

NCT00719511 ↗

Phase 2 Completed 132 enrolled University of Zurich

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Evaluation of patch as specific immunotherapy in allergic patients

Timeline

Start: 2008-02
Primary completion: 2009-11
Completion: 2009-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Purified allergen	Unknown	—	—

Indications